IRBT · As filed with the SEC

Irobot cash flow statement, by quarter

The statement as Irobot presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousands	Q3 2025^† 3 months ended Sep 27, 2025	Q2 2025^† 3 months ended Jun 28, 2025	Q1 2025 3 months ended Mar 29, 2025	Q4 2024^† 3 months ended Dec 28, 2024	Q3 2024^† 3 months ended Sep 28, 2024	Q2 2024^† 3 months ended Jun 29, 2024	Q1 2024 3 months ended Mar 30, 2024	Q4 2023^† 3 months ended Dec 30, 2023
Cash flows from operating activities:
Net loss	(21,526)^†	(22,808)^†	(87,273)	(77,108)^†	(6,371)^†	(70,646)^†	8,607	(63,593)^†
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,534^†	1,762^†	2,623	4,755^†	5,796^†	5,304^†	5,812	11,424^†
Loss on equity investment	1,172^†	394^†	0	(745)^†	0^†	0^†	(375)	0^†
Stock-based compensation	3,854^†	3,762^†	5,314	6,539^†	5,479^†	4,510^†	7,948	10,176^†
Provision for inventory excess and obsolescence	325^†	631^†	384	1,689^†	85^†	11,515^†	—	4,638^†
Change in fair value of term loan	(3,766)^†	(23,278)^†	25,965	11,042^†	8,769^†	5,754^†	(1,008)	612^†
Debt issuance costs expensed under fair value option	(16,828)^†	5,214^†	11,614	54^†	52^†	238^†	239	0^†
Deferred income taxes, net	4,367^†	0^†	292	(1,740)^†	1,031^†	(1,555)^†	(127)	2,448^†
Other	1,488^†	1,474^†	1,638	—	(2,460)^†	(406)^†	(3,452)	—
Changes in operating assets and liabilities — (use) source
Accounts receivable	(1,079)^†	(23,891)^†	20,156	49,195^†	(31,313)^†	(29,325)^†	38,565	(3,805)^†
Inventory	(53,847)^†	(20,250)^†	7,434	69,491^†	(46,387)^†	19,782^†	16,266	92,775^†
Other assets	115^†	2,565^†	3,135	6,368^†	(10,519)^†	20,072^†	6,045	1,397^†
Accounts payable	30,539^†	69,070^†	(9,642)	(87,644)^†	80,549^†	10,726^†	(74,601)	(33,508)^†
Accrued expenses and other liabilities	(11,550)^†	(24,014)^†	(8,100)	12,440^†	(14,954)^†	2,361^†	(3,232)	(8,266)^†
Net cash used in operating activities	(47,586)^†	(30,157)^†	(26,460)	(2,746)^†	(10,243)^†	(21,670)^†	1,437	(1,156)^†
Cash flows from investing activities:
Additions of property and equipment	0^†	0^†	0	0^†	0^†	0^†	(118)	270^†
Purchase of investments	0^†	(6)^†	(8)	(80)^†	(10)^†	(46)^†	0	(20)^†
Net cash provided by (used in) investing activities	594^†	(6)^†	(8)	(80)^†	(10)^†	(46)^†	(118)	250^†
Cash flows from financing activities:
Proceeds from employee stock plans	—	—	—	0^†	0^†	0^†	0	0^†
Income tax withholding payment associated with restricted stock vesting	(114)^†	(173)^†	(84)	(16)^†	(28)^†	(73)^†	(390)	(878)^†
Proceeds from issuance of common stock, net of issuance costs	0^†	0^†	0	(62)^†	1,417^†	12,310^†	5,632	0^†
Proceeds from credit facility	—	—	—	—	—	—	0	—
Repayment of term loan	0^†	—	—	0^†	0^†	0^†	(34,947)	0^†
Proceeds from term loan	—	—	—	0^†	—	—	—	0^†
Payment of debt issuance costs	—	—	—	(54)^†	(52)^†	(238)^†	(239)	0^†
Net cash used in financing activities	(114)^†	(4,173)^†	(84)	(132)^†	1,337^†	11,999^†	(29,944)	(878)^†
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(58)^†	992^†	922	(971)^†	398^†	(29)^†	882	(1,737)^†
Net decrease in cash, cash equivalents and restricted cash	(47,164)^†	(33,344)^†	(25,630)	(3,929)^†	(8,518)^†	(9,746)^†	(27,743)	(3,521)^†
Cash, cash equivalents and restricted cash, at beginning of period	78,977	112,321	137,951	141,880	150,398	160,144	187,887	191,408
Cash, cash equivalents and restricted cash, at end of period	31,813	78,977	112,321	137,951	141,880	150,398	160,144	187,887

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.